eohilia
(Budesonide)TAKEDA PHARMACEUTICALS AMERICA, INC.
Usage: EOHILIA™ is indicated for 12 weeks of treatment in adults and pediatric patients aged 11 and older with eosinophilic esophagitis (EoE). It is not proven safe or effective for EoE treatment beyond 12 weeks.